Goodwill and Other Intangible Assets, Net (Tables)

6 Months Ended

Jun. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill

The following table provides a summary of the activity in goodwill by segment for the six months ended June 30, 2016 (in thousands):

	Consumer Health		Prescription Pharmaceuticals			Total
Balances at December 31, 2015	$	16,717	$	267,993		$	284,710
Currency translation adjustments	—		(331		)	(331		)
Acquisitions	—		—			—
Impairments	—		—			—
Dispositions	—		—			—
Balances at June 30, 2016	$	16,717	$	267,662		$	284,379

Schedule of other intangible assets

The following table sets forth information about the net book value of the Company’s other intangible assets as of June 30, 2016 and December 31, 2015, and the weighted average remaining amortization period as of June 30, 2016 and December 31, 2015 (dollar amounts in thousands):

	Gross Amount		Accumulated Amortization			Reclass-ifications			Impairment			Net Balance		Wtd Avg Remaining Amortization Period (years)
June 30, 2016
Product licensing rights	$	789,643	$	(163,832	)	$	—		$	(200	)	$	625,611	10.5
IPR&D	186,932		—			—			—			186,932		N/A - Indefinite lived
Trademarks	16,000		(3,613		)	—			—			12,387		18.1
Customer relationships	6,301		(3,744		)	—			—			2,557		9.8
Other intangibles	11,235		(3,467		)	—			—			7,768		6.3
Non-compete agreement	2,274		(2,274		)	—			—			—		—
	$	1,012,385	$	(176,930	)	$	—		$	(200	)	$	835,255
December 31, 2015
Product licensing rights	$	782,269	$	(132,642	)	$	38,000		$	(34,000	)	$	653,627	13.2
IPR&D	227,559		—			(38,000		)	(2,627		)	186,932		N/A - Indefinite lived
Trademarks	16,000		(2,982		)	—			—			13,018		21.8
Customer relationships	6,493		(3,716		)	—			—			2,777		11.7
Other intangibles	11,235		(2,600		)	—			—			8,635		7.9
Non-compete agreement	2,167		(2,167		)	—			—			—		—
	$	1,045,723	$	(144,107	)	$	—		$	(36,627	)	$	864,989